With headquarters in New Jersey, BioNeutral Group is a specialty technology-based life science company that has developed a unique technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms which include bacteria, mold, fungi and spores. Today, BioNeutral announced the addition of Dr. Andy Kielbania to their Board of Directors.
Dr. Kielbania has over 35 years experience in the field and is a renowned name throughout the sector. Dr. Kielbania joined BioNeutral in 2005 as their Chief Science Officer after a distinguished career as an inventor, researcher and developer.
When asked what this move will mean to the future of BioNeutral, Stephen J. Browand, who serves as the company’s CEO, was quoted as saying, “After more than five years of dedicated service to the Company, and tremendous contributions to our science, technology and platform for growth, we are pleased to add Dr. Kielbania to our Board of Directors. Andy has been instrumental in our progress to date and we will benefit from his expertise in the years to come as we transition from product development to commercialization.”
Currently, BioNeutral is trading in the $0.41 range. With the addition of Dr. Andy Kielbania to their Board of Directors and a strong technology platform in place, BioNeutral is a company to keep an eye on.
To learn more about this up-and-coming company, visit its website at: www.bioneutralgroup.com